Advanced glycation end-products (AGEs): Formation, chemistry, classification, receptors, and diseases related to AGEs
A Twarda-Clapa, A Olczak, AM Białkowska… - Cells, 2022 - mdpi.com
Advanced glycation end-products (AGEs) constitute a non-homogenous, chemically diverse
group of compounds formed either exogeneously or endogeneously on the course of …
group of compounds formed either exogeneously or endogeneously on the course of …
Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease
T Guo, C Wantono, Y Tan, F Deng, T Duan… - Frontiers in …, 2023 - frontiersin.org
The extracellular matrix (ECM) provides physical support and imparts significant
biochemical and mechanical cues to cells. Matrix stiffening is a hallmark of liver fibrosis and …
biochemical and mechanical cues to cells. Matrix stiffening is a hallmark of liver fibrosis and …
Plasma pentosidine as a useful biomarker of sarcopenia, low gait speed, and mortality in patients with cirrhosis
C Saeki, M Saito, A Tsubota - Frontiers in Medicine, 2023 - frontiersin.org
Purpose The accumulation of advanced glycation end products (AGEs) is associated with
various diseases and age-related impairments, including loss of muscle mass and function …
various diseases and age-related impairments, including loss of muscle mass and function …
Epigenetic contributions to cancer: Exploring the role of glycation reactions
Advanced Glycation End-products (AGEs), with their prolonged half-life in the human body,
are emerging as potent diagnostic indicators. Early intervention studies, focusing on AGE …
are emerging as potent diagnostic indicators. Early intervention studies, focusing on AGE …